Financial statements Apteka Gemini
Balance sheet data of APTEKA GEMINI
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 38 989 646,38 | 36 537 000,15 | 42 013 253,26 | 46 649 681,25 | 63 287 747,24 |
| A. Fixed assets | 2 025 477,85 | 2 169 659,78 | 1 926 900,89 | 1 874 246,61 | 11 897 474,17 |
| B. Current assets | 36 964 168,53 | 34 367 340,37 | 40 086 352,37 | 44 775 434,64 | 51 390 273,07 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 38 989 646,38 | 36 537 000,15 | 42 013 253,26 | 46 649 681,25 | 63 287 747,24 |
| A. Equity | -2 175 847,74 | 352 307,14 | 2 316 080,32 | 4 398 118,96 | 6 310 066,73 |
| B. Liabilities and provisions for liabilities | 41 165 494,12 | 36 184 693,01 | 39 697 172,94 | 42 251 562,29 | 56 977 680,51 |
| I. Long-term liabilities | 26 533 361,87 | 19 533 361,87 | 0,00 | - | 12 800 386,32 |
| II. Short-term liabilities | 12 959 994,34 | 15 127 163,99 | 37 958 494,32 | 40 381 224,19 | 42 529 213,57 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.